D
Glaukos Corporation GKOS
$103.34 $5.555.68%
Recommendation
Sell
Prev Close
$97.79
Volume
1,403,507
Avg Vol (90D)
722,895
Market Cap
$5.53B
Dividend & Yield
--
52-Week Range
$84.08 - $163.71
P/E (TTM)
--
EPS (TTM)
-$2.81
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Fair
Volatility Index
Fair
Dividend Index
--
Headlines
Glaukos Corp (GKOS) Trading 3.36% Higher on Mar 12
3/12/2025 - GuruFocus
Glaukos (NYSE:GKOS) Stock Price Down 9.8% - Here's What Happened
3/11/2025 - MarketBeat
radiusxr and glaukos corporation announce a new collaboration with topcon healthcare inc and the launch of inspire a nextgeneration visual field solution
3/11/2025 - GuruFocus
Glaukos, RadiusXR collaborate with Topcon Healthcare on vision testing platform
3/11/2025 - TipRanks Financial Blog
Glaukos, RadiusXR collaborate with Topcon Healthcare on vision testing platform
3/11/2025 - The Fly
RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire: A Next-Generation Visual Field Solution
3/11/2025 - Business Wire
Essex Investment Management Co. LLC Trims Position in Glaukos Co. (NYSE:GKOS)
3/11/2025 - Ticker Report
Charles Schwab Investment Management Inc. Purchases 8,936 Shares of Glaukos Co. (NYSE:GKOS)
3/10/2025 - MarketBeat
Glaukos Co. (NYSE:GKOS) Given Consensus Recommendation of "Moderate Buy" by Brokerages
3/10/2025 - MarketBeat
SBI Securities Co. Ltd. Purchases Shares of 1,018 Glaukos Co. (NYSE:GKOS)
3/8/2025 - Ticker Report
Aigen Investment Management LP Raises Holdings in Glaukos Co. (NYSE:GKOS)
3/7/2025 - Ticker Report
Glaukos Co. (NYSE:GKOS) Position Increased by Lisanti Capital Growth LLC
3/7/2025 - Ticker Report
Bank of New York Mellon Corp Increases Holdings in Glaukos Co. (NYSE:GKOS)
3/5/2025 - MarketBeat
Is Glaukos Corporation (GKOS) the Best Medical Technology Stock to Buy According to Analysts?
3/5/2025 - Insider Monkey
Glaukos (NYSE:GKOS) Trading Down 6.3% - Here's What Happened
3/3/2025 - Ticker Report
Glaukos (NYSE:GKOS) Shares Down 6.3% - Should You Sell?
3/3/2025 - MarketBeat
Glaukos Corp (GKOS) Trading Down 5.45% on Mar 3
3/3/2025 - GuruFocus
Truist Financial Corp Sells 5,319 Shares of Glaukos Co. (NYSE:GKOS)
3/1/2025 - MarketBeat
7 Best Medical Technology Stocks To Buy According To Analysts
3/1/2025 - Insider Monkey
GKOS Crashes Almost 25% After Q4 Earnings: How to Play the Stock?
2/28/2025 - Zacks Investment Research
Glaukos Corporation (NYSE:GKOS) Shares Slammed 26% But Getting In Cheap Might Be Difficult Regardless
2/28/2025 - Simply Wall St
Taylor Frigon Capital Management LLC Decreases Position in Glaukos Co. (NYSE:GKOS)
2/27/2025 - MarketBeat
Glaukos Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
2/25/2025 - Simply Wall St
Glaukos Corp (GKOS) Announces FDA Review of Epioxa NDA for Keratoconus Treatment
2/25/2025 - GuruFocus
FDA accepts Glaukos application for Epioxa for keratoconus
2/24/2025 - Seeking Alpha - Healthcare
Income Statement
Total Revenue (TTM)
$383.48M
EBITDA (TTM)
-$72.49M
EBIT (TTM)
-$108.14M
Net Income (TTM)
-$146.37M
Balance Sheet
Total Assets (Q)
$974.76M
Total Debt (Q)
$105.87M
Total Liabilities (Q)
$207.83M
Book Value Per Share (Q)
$13.59
Cash Flow
Cash from Operations (TTM)
-$61.32M
Cash from Investing (TTM)
$47.83M
Cash from Financing (TTM)
$91.54M
Net Change in Cash (TTM)
$75.04M
Filings
Filing Date
Tuesday, February 25, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Beginning of May (est)
Price History
Loading...
Beta
1.01
7-Day Total Return
-5.32%
30-Day Total Return
-35.28%
60-Day Total Return
-27.68%
90-Day Total Return
-24.98%
Year to Date Total Return
-30.96%
1-Year Total Return
18.78%
2-Year Total Return
128.38%
3-Year Total Return
112.68%
5-Year Total Return
164.30%
52-week Low
Mar 15, 2024 - $84.08
52-week High
Jan 23, 2025 - $163.71
Valuation
Market Cap
$5.53B - Mid Cap
Enterprise Value
$5.32B
Price/Sales (TTM)
14.17
Price/Book (Q)
7.20
Dividends and Shares
Shares Outstanding
55.58M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.glaukos.com
Phone Number
949 367 9600
Address
One Glaukos Way
Aliso Viejo, CA 92656
Country
United States
Year Founded
1998
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States... more
NYSE 03/12/2025 4:00PM Eastern Quotes delayed
Weiss Ratings